Interpreting Adverse Signals in Diabetes Drug Development Programs

por Bailey, Clifford J.
Publicado 2013

Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin

por Bailey, Clifford J., Gwilt, Mike
Publicado 2022

Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease

por Bailey, Clifford J., Day, Caroline, Bellary, Srikanth
Publicado 2022

Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

por Lipska, Kasia J., Bailey, Clifford J., Inzucchi, Silvio E.
Publicado 2011

Metformin and the gastrointestinal tract

por McCreight, Laura J., Bailey, Clifford J., Pearson, Ewan R.
Publicado 2016

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes

por Bailey, Clifford J., Del Prato, Stefano, Wei, Cheryl, Reyner, Daniel, Saraiva, Gabriela
Publicado 2019

Functional Enhancement of Electrofusion-derived BRIN-BD11 Insulin-secreting Cells After Implantation into Diabetic Mice

por Davies, Emma L., Abdel-Wahab, Yasser H. A., Flatt, Peter R., Bailey, Clifford J.
Publicado 2001

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

por Jabbour, Serge, Seufert, Jochen, Scheen, Andre, Bailey, Clifford J., Karup, Cathrina, Langkilde, Anna M.
Publicado 2017

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

por Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Publicado 2013

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

por Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Publicado 2013

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

por Fouqueray, Pascale, Pirags, Valdis, Inzucchi, Silvio E., Bailey, Clifford J., Schernthaner, Guntram, Diamant, Michaela, Lebovitz, Harold E.
Publicado 2013

The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios

por McGill, Margaret, Blonde, Lawrence, Chan, Juliana C.N., Khunti, Kamlesh, Lavalle, Fernando J., Bailey, Clifford J.
Publicado 2016

Odd chain fatty acid metabolism in mice after a high fat diet

por Ampong, Isaac, John Ikwuobe, O., Brown, James E.P., Bailey, Clifford J., Gao, Dan, Gutierrez-Merino, Jorge, Griffiths, Helen R.
Publicado 2022

Plasma irisin levels predict telomere length in healthy adults

por Rana, Karan S., Arif, Muhammad, Hill, Eric J., Aldred, Sarah, Nagel, David A., Nevill, Alan, Randeva, Harpal S., Bailey, Clifford J., Bellary, Srikanth, Brown, James E.
Publicado 2014

Age‐associated changes in long‐chain fatty acid profile during healthy aging promote pro‐inflammatory monocyte polarization via PPARγ

por Pararasa, Chathyan, Ikwuobe, John, Shigdar, Shahjahan, Boukouvalas, Alexis, Nabney, Ian T., Brown, James E., Devitt, Andrew, Bailey, Clifford J., Bennett, Stuart J., Griffiths, Helen R.
Publicado 2015

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

por Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Publicado 2014

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

por Home, Philip, Riddle, Matthew, Cefalu, William T., Bailey, Clifford J., Bretzel, Reinhard G., del Prato, Stefano, Leroith, Derek, Schernthaner, Guntram, van Gaal, Luc, Raz, Itamar
Publicado 2014

Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels

por Rana, Karan S., Pararasa, Chathyan, Afzal, Islam, Nagel, David A., Hill, Eric J., Bailey, Clifford J., Griffiths, Helen R., Kyrou, Ioannis, Randeva, Harpal S., Bellary, Srikanth, Brown, James E.
Publicado 2017